Scripta Medica (Jan 2010)

Implementation of secondary prevention methodologies in ischemic heart disease

  • Wong Nathan D.,
  • Vulić Duško B.,
  • Šobot Marko

Journal volume & issue
Vol. 41, no. 1
pp. 29 – 35

Abstract

Read online

Ischemic heart disease (IHD) remains a major cause of mortality, morbidity, and disability in the U.S. and other developed countries and is an emerging epidemic in developing countries. As a result of therapeutic and preventive measures to control the IHD pandemic, mortality has declined steadily during the last several decades with consequent gains in life expectancy; however, this decrease in mortality started to plateau in the 1990's.1,2 Secondary prevention is identifying and treating people with established disease and those at very high risk of developing ischemic heart disease, which involves the treatment and rehabilitation of patients with known ischemic heart disease to prevent future cardiovascular events, including myocardial infarction, stroke, and heart failure.

Keywords